Elanco Animal Health Incorporated Capitalized Computer Software, Amortization
Elanco Animal Health Incorporated (ELAN) reported Capitalized Computer Software, Amortization of $6.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CapitalizedComputerSoftwareAmortization1 · last filed 2026-05-06
- Elanco Animal Health Incorporated capitalized computer software, amortization for the quarter ending 2026-03-31 was $6.00M, a 33.33% decline year-over-year.
- Elanco Animal Health Incorporated capitalized computer software, amortization for the quarter ending 2025-09-30 was $8.00M, a 20.00% decline year-over-year.
- Elanco Animal Health Incorporated capitalized computer software, amortization for the quarter ending 2025-06-30 was $8.00M, a 20.00% decline year-over-year.
- Elanco Animal Health Incorporated capitalized computer software, amortization for the quarter ending 2025-03-31 was $9.00M, a 10.00% decline year-over-year.
| Period end | Capitalized Computer Software, Amortization 3 month | Capitalized Computer Software, Amortization 6 month | Capitalized Computer Software, Amortization 9 month |
|---|---|---|---|
| 2026-03-31 | $6.00M 10-Q · filed 2026-05-06 | ||
| 2025-09-30 | $8.00M 10-Q · filed 2025-11-05 | $16.00M derived: sum of 2 quarters · filed 2025-11-05 | $25.00M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $8.00M 10-Q · filed 2025-08-07 | $17.00M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $9.00M 10-Q · filed 2026-05-06 | ||
| 2024-09-30 | $10.00M 10-Q · filed 2025-11-05 | $20.00M derived: sum of 2 quarters · filed 2025-11-05 | $30.00M 10-Q · filed 2025-11-05 |
| 2024-06-30 | $10.00M 10-Q · filed 2025-08-07 | $20.00M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $10.00M 10-Q · filed 2025-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |